DSM-Firmenich AG (DSFIR.AS)
DSM-Firmenich AG (DSFIR.AS) Stock Price, Analysis & Data
| Precio de compra | n/a |
| Capitalización de mercado | 21.81B |
| Ingresos (TTM) | 9.05B |
| Beneficio neto (TTM) | 324M |
| Beta | 0.56 |
| EPS (TTM) | 1.4 |
| Ratio PER (TTM) | 63.21 |
| Adelante PE | 21.64 |
| P/B (TTM) | 1.24 |
| P/S (TTM) | 2.41 |
| Earnings Date | n/a |
| Precio de venta | n/a |
| Volumen | 532,268 |
| Volumen medio (20D) | 1,006,343 |
| Abierto | 87.54 |
| Anterior Cerrar | 87.48 |
| Rango del día | 87.30 - 88.78 |
| Rango de 52 semanas | 55.22 - 95.00 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | $2.5 (2.86%) |
| Fecha ex dividendo | 11 may 2026 |
Acerca de DSFIR.AS
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food ...
Desempeño financiero
En 2025, los ingresos de DSM-Firmenich fueron 9.03B, una disminución de -0.22% en comparación con 9.05B del año anterior. Las ganancias fueron -1.08B, una disminución de -532.4%.
Cifras financieras en EUR Estados financieros
3 meses hace · Simply Wall St.
DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation UpsideDSM-Firmenich (ENXTAM:DSFIR) has partnered with Medisca to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients in the U.S. market. The agreement focuses on supplying Europe...